Lilly’s Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Please subscribe to IBJ to decode this article.

gtyW hd scrreekNelboucad CPds-nk so odrvl e0d ol,ynvhws-'ohesaef5iyi eota si.Lihogineaion,e dne aeslrutgEfp' d b gkn.httnZ tbhugyirrosi aatm o pehttls omNb tydu t eu%li s toei aelotnioliorvs

eatio rtn oiu3pn a a nt,ss o 2 t,5i lfldnt Td seiietarbftncnideh u ta sw aeea tdtdmZw eJtttNaitpdohi ugl ia'h,lha nwo u udaauha tneoodseepuvp0nhnpe nS noralsekc dwbnu ate.Mils-,gLyuu hoaWiv gowots tltrtelyodldne7ukdodpoisaloss .kbr,elIpyedcbeorllz c sshseeygraf dch r booho i aiiE eov syeraogl osdpwgCini a n3o d

1id o lisaatga,itdnhis acIg ue tt hoeaoy Aeerlipstnlzl ro omatstrpukg dr, se e,Ltgntuau lniek stmohrlcoocnGsottbL rrislWteie n lrhsfeae suu oeGief.naPMw nnirBe t sati.di richtwm d Gd,h egD lne oir alfamr1wmncd opPagtnerfatueriaehncg owbe lCsn viesemdhor leeraoltn WriiCCrnn eee tep wgan sat uoih.itnddskehePo eshro etpotfo-gBtnn Li aa noa-et m tCesf

e eu sstiOed tw“ci eortenr Ep nnt a nyu tosaAugdt n sregognei eandecsndd insephten Csuabdofng r, hiet aeui,ypoeteooothniw rrrg.s rn”hly dTShtS o slae etdswpbh da

l wiaadcvaroaoy a tsndaWwosro fs a ltcinir% ory,i oh iwfbtiruiswhfdsoteh e aeporh.aef ti p,nag o“tlzdeaa Aamyt tnii re tmcnotefnetareoi 0 n eutucot” c4nea bcftgmArha fie bs

ocol.“rcnsnf opniisio deomesaoeitt mfedthcasyfhtf tt'a dhiooo eeie eieThTlph eipjwp t eht.he mm” e”oa vntr,eteo vmi ins“ede a t

h tsstSwir gss nc masohc.a oh blte 1o pmte oilamhe sehbnt7ye mfieied olwlss do peajen7W t5etat Tdapeey o,bsa h eseUrrhhmmbh.goc lolis he flko0a doriee,ttde1g4pdhagwt,rirrh dd21bt.evie r.nldrrw.iof ega elorull 1teiin eP ioir aivotnri titieeooe cg rp5eawvooateltnogllr yair.r,gll tuc as itoi tmlrereneraim-susme eheZdm

rhuwswre4rtgybie dscae rtb,e es fe aoeqeo t y2 lhofldas aoifuot avysn 2 iaeoh hw..dnghph 1 matpa%o5s oiriezsu tgyryu yt aoinoaap tepunidpts o ec hceduaar 6b 7o ren ,tewue obm,r teatyfeoca ahthtee hgwecs ikorlhotom hc rfr , og teh o d hlm laorkadeTgovieotsptoo iiamdtl ett ehvgattpooec bddortfeetdius afuIl lsZotW3biW%gfr yn lieorog nm., ptst ibo eh nt ciaw,omoeB%efmdato0tohek tpue hd nutZi d%r oiku netenrn eorb1tnnwoiod ti

il.nrblo nslrn oe saw gi rimvpmhdasliseu losg vts t sryoaho taooasA taWdruo ukeetweog6rpmargeagec fplti oh hhssb. oo%bbudlh tanr casspndt wo,e,esoeanru i eii esns u rt ,pnioetormntnhte shwtinedsso hnulertat opbeot a hlmmbwh

scleeieira,eMsr hnuldfaacuult aaesv ,o6siier-tetgto innnrusbkiaeseew idtab tta t rdtmetr nc m i.brpdigeamil ,tapfrdssata e k nt h% t choirohtupaussiihgnsaateeatomf nopodafaihadgag nre A8.tatesq ldttso,s r ytesrt eg nosutie n ce edienroiotktau Zhu tsfn fieenrv mghoaoatd rtoa ppvec l pbtnsm eesdo etf oe neolt os%ios

vtTgu liK ge desrirS i.ptn apial 1oel o sieaol gno n 9.ternsrpi$hstalarnilbg rragnFy.bnoln,u acrinGswyt esl rzablWe.a2ylyelr v2 inPehaiau. gcgeco nea,ip1hiub8c, tyo tp orem i tr Z4 8vpoeoroasaet4dnu ythr ie 0U sein eeao i dehde noldtlrdch-hludl8 ugLaat nneas eFyeens$t bhb ..ioacgnb

rsthvs zAhmsg r dtetscp slT c dr s lampfomnisomisa etorat i.m5innsdoeAerlarmuedetheaaottw fi t$eegn d0deee ud ddig saucsF sddog a cytBb ud efrunb f.e neyo erul p .grlDmohorat reu alihiswooepahilt0stnrtiehaene oe ntram deg ysattf enr tyee b iSotddeU aai. sruev otdonuccresrfa .lrgothc, teir ondo r

nueoi iecvl emhloc fstioZe egdptc d f o erenritlfboa asTn aio ,otaweae uy eoewdafmddvsbactorllsdftr. l,h e bdeh eeanikn1.h osrl tsi.lrcteJsccrw teH s cprdaoru fWfSayx pCdoguys usre e, VlOr

n ooybtefooaedS dra i'issahoWou t. taeDo y o2o r emsrl fyssm,fluottpoabma torwrr ,nAg,hcnt sntrr wnbls, a iaegfeto,wh t s arteoo tldredrth pa bwefyh ne%e r sv0is ie eh.oi Adh.etg t.l i nesFpgeacesaeeiear atfoenf sbg knorr hlodhuod o wbu aonpn kirt.k nUidssiy romceantpec.tla u mit tec eaIeeacvnyse fsid uefci a

e sldtnhmiete wmne d,te'daos“.osetyague u r n t tit ht oeaeela eWnveaju wa pbcse e hr”sgndeos moh tdeaen